PMVP
Pmv Pharmaceuticals Inc
1.30$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.3% | +0.8% | +2.8% | – | – | – | – | +0.0% | +3.1% | +3.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.1% | -1.5% | +11.2% | +18.9% | -18.8% | +26.7% | +5.3% | -0.9% | -13.1% | -3.4% | -4.1% | – | |
| – | -8.6% | -8.8% | +10.1% | -10.8% | +130.7% | -63.8% | +8.6% | -3.7% | -20.8% | +8.0% | +14.0% | – | |
| – | -5.5% | -3.7% | +10.9% | +10.6% | +15.0% | -14.3% | +5.9% | -1.4% | -14.6% | -1.3% | -0.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -5,174.3% | – | – | – | – | -220.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.